Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-063600

Options or other derivatives

  • Chief Legal & Adm. Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
McDowell Caryn Gordon Chief Legal & Adm. Officer 2020-12-11 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
McDowell Caryn Gordon Chief Legal & Adm. Officer 2020-12-11 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…